Preeclampsia

Preeclampsia: A Comprehensive Academic Overview

Introduction

Preeclampsia is a pregnancy-specific hypertensive disorder that remains a leading cause of maternal and perinatal morbidity and mortality worldwide. It typically occurs after 20 weeks of gestation and is characterized by new-onset hypertension accompanied by proteinuria or signs of organ dysfunction. Despite advances in obstetric care, preeclampsia continues to pose significant clinical challenges, particularly in low-resource settings.

Definition and Diagnostic Criteria

According to the American College of Obstetricians and Gynecologists, preeclampsia is defined as:

• Blood pressure ≥140/90 mmHg on two occasions at least 4 hours apart after 20 weeks of gestation
  AND
• One or more of the following:
  • Proteinuria (≥300 mg/24-hour urine collection)
  • Thrombocytopenia (platelets <100,000/µL)
  • Renal insufficiency
  • Elevated liver enzymes
  • Pulmonary edema
  • New-onset cerebral or visual disturbances

 

Epidemiology

Preeclampsia affects approximately 2–8% of pregnancies globally. The burden is significantly higher in developing countries, where access to prenatal care is limited. It contributes substantially to maternal deaths and adverse neonatal outcomes such as preterm birth and intrauterine growth restriction (IUGR).

Pathophysiology

The exact etiology of preeclampsia remains incompletely understood, but it is widely accepted to involve abnormal placentation and endothelial dysfunction.

Key mechanisms include:

1. Impaired trophoblastic invasion
   In normal pregnancy, trophoblasts remodel spiral arteries into low-resistance vessels. In preeclampsia, this process is incomplete, leading to placental ischemia.
2. Endothelial dysfunction
   Placental ischemia triggers the release of antiangiogenic factors such as soluble fms-like tyrosine kinase-1 (sFlt-1), which disrupt vascular homeostasis.
3. Systemic inflammation
   Increased inflammatory cytokines contribute to vascular damage and multi-organ involvement.

Risk Factors

Several maternal and pregnancy-related factors increase the risk:

• First pregnancy (nulliparity)
• Advanced maternal age (>35 years)
• Multiple gestation
• History of preeclampsia
• Chronic hypertension
• Diabetes mellitus
• Obesity
• Autoimmune diseases such as lupus

Clinical Features

Preeclampsia may present with a range of symptoms:

Mild symptoms:

• Elevated blood pressure
• Proteinuria
• Mild edema

Severe features:

• Severe headache
• Visual disturbances (blurred vision, scotoma)
• Epigastric or right upper quadrant pain
• Shortness of breath (pulmonary edema)
• Reduced urine output

Complications

If untreated, preeclampsia can progress to serious complications:

Maternal:

• Eclampsia (seizures)
• HELLP syndrome
• Stroke
• Liver rupture
• Renal failure

Fetal:

• Intrauterine growth restriction (IUGR)
• Preterm birth
• Placental abruption
• Stillbirth

Management

Management depends on gestational age and disease severity.

1. Expectant Management

• Close monitoring of maternal and fetal condition
• Blood pressure control (e.g., labetalol, nifedipine)
• Regular laboratory tests

2. Severe Preeclampsia

• Hospitalization
• Magnesium sulfate for seizure prophylaxis
• Antihypertensive therapy

3. Definitive Treatment

• Delivery of the fetus and placenta is the only cure
  Timing depends on maternal and fetal stability.

Prevention

Preventive strategies include:

• Low-dose aspirin in high-risk women (recommended by World Health Organization)
• Calcium supplementation in populations with low dietary intake
• Early antenatal care and risk assessment

Prognosis and Long-Term Outcomes

Women with a history of preeclampsia have an increased risk of:

• Future cardiovascular disease
• Chronic hypertension
• Recurrence in subsequent pregnancies

Early diagnosis and management significantly improve outcomes.

Conclusion

Preeclampsia is a complex multisystem disorder with significant implications for both mother and fetus. Understanding its pathophysiology, early recognition of symptoms, and timely intervention are critical in reducing associated morbidity and mortality. Strengthening antenatal care services and increasing awareness remain essential components in combating this condition globally.

References

1. American College of Obstetricians and Gynecologists. Hypertension in Pregnancy. ACOG Practice Bulletin.
2. World Health Organization. Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia.
3. National Institute for Health and Care Excellence. Hypertension in Pregnancy: Diagnosis and Management.
4. International Society for the Study of Hypertension in Pregnancy. Global Recommendations on Preeclampsia.
5. Roberts JM, Hubel CA. (2009). The Two Stage Model of Preeclampsia. Placenta Journal.
6. Redman CW, Sargent IL. (2005). Latest Advances in Understanding Preeclampsia. Science.

Medical Disclaimer

The information provided on this website is for educational and informational purposes only.

Although the content is related to medical topics such as pregnancy and women’s health, it should not be considered professional medical advice, diagnosis, or treatment.

Always seek the advice of a qualified healthcare professional regarding any medical condition or health concern.

The author and website are not responsible for any actions taken based on the information provided on this site.

 Dr.Ifrah Hassan Hilaac.

https://www.drifrahhassanhilac.com/2026/03/how-to-get-restful-sleep-during.html